Blackstone closing in on Aurobindo's injectables business - Economic Times

The keenly contested transaction, now in the final stages of negotiations, pits Blackstone against Baring Private Equity Asia, the only other contender still in the fray and is likely to see listed Aurobindo getting split into two.

Blackstone has emerged as the frontrunner to acquire the wholly owned injectables arm of Aurobindo Pharma, valuing the business at around ?26,000-30,000 crore ($3.4-4 billion), making it arguably the… [+6442 chars]

full article...